QT interval dynamics predict mortality in high-risk patients after myocardial infarction

Scand Cardiovasc J. 2002 Sep;36(5):276-81. doi: 10.1080/140174302320774474.

Abstract

Objective: The purpose of this study was to evaluate the prognostic properties of the QT/RR relationship in survivors of myocardial infarction with severe left ventricular dysfunction.

Design: The QT/RR interval slope was assessed from 24-h electrocardiographic recordings obtained from 241 patients representative of survivors of an acute myocardial infarction with an ejection fraction < or =35%. During a median follow-up of 752 days, 63 patients died.

Results: In a multivariate analysis QT/RR at night-time was an independent predictor of all-cause mortality. A linear all-cause mortality predictor score was calculated from age, ejection fraction, QRS duration and QT/RR night, allowing identification of a high-risk one-third of the patients with a relative risk of death at 4.0.

Conclusion: This study demonstrates independent prognostic information of night-time QT/RR dynamics in patients at high risk after myocardial infarction. A linear predictor score calculated from age, ejection fraction, QRS duration and QT/RR night identifies a high-risk one-third of the patients with a 1-year mortality of 36% vs 9% in the remaining patients.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / epidemiology
  • Arrhythmias, Cardiac / physiopathology
  • Electrocardiography, Ambulatory*
  • Female
  • Follow-Up Studies
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Humans
  • Male
  • Multivariate Analysis
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / epidemiology*
  • Myocardial Infarction / physiopathology
  • Observer Variation
  • Phenethylamines / therapeutic use
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Factors
  • Sulfonamides / therapeutic use
  • Survival Analysis
  • Treatment Outcome
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / epidemiology
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Arrhythmia Agents
  • Phenethylamines
  • Sulfonamides
  • dofetilide